Straits Times Index
3,090.31 +17.32 (+0.56%) Nikkei
33,431.51 -55.38 (-0.17%) Hang Seng
16,830.30 -212.58 (-1.25%) FTSE 100
7,529.35 +75.60 (+1.01%) Bitcoin USD
38,788.59 +208.07 (+0.54%) CMC Crypto 200
802.76 +11.20 (+1.41%)
22nd Century Group, Inc. (XXII)
After hours:
| Previous close | 0.2600 |
| Open | 0.2563 |
| Bid | 0.2600 x 900 |
| Ask | 0.2800 x 800 |
| Day's range | 0.2200 - 0.2650 |
| 52-week range | 0.2010 - 18.9750 |
| Volume | |
| Avg. volume | 966,461 |
| Market cap | 8.183M |
| Beta (5Y monthly) | 1.83 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
22nd Century Appoints Larry Firestone as Chairman and CEO
Turnaround Veteran to Focus on Unlocking Shareholder Value in Tobacco AssetsBUFFALO, N.Y., Nov. 29, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (“22nd Century” or the “Company”), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced the appointment of Lawrence (Larry) Firestone as the Company's Chairman and Chief Executive Officer. Nora Sullivan, former Chair of the Board, commented, “Larry is a seasoned exec
- GlobeNewswire
22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchise
Sale Expected to Result in Immediate and Significant Reduction in Operating Costs and Cash RequirementsBUFFALO, N.Y., Nov. 27, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (the “Company” or “22nd Century”), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced it has reached an agreement to sell substantially all of its GVB Biopharma (“GVB”) hemp/cannabis operations to Specialty Acquisition Corporation
- GlobeNewswire
22nd Century Group Continues VLN® Expansion, Now Retailing in More Than 5,100 Stores
Adds another 500+ storesBUFFALO, N.Y., Nov. 08, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today announced that it has again expanded its VLN® retail presence with more than 500 additional locations across 11 states. With these latest additions, 22nd Century Group’s FDA-authorized VLN® reduced nicotine conten
